Concepedia

Yi‐Hung Carol Tan

YC

Statistics

Publications

24

Citations

976

H-Index

18

Active since

2004

Affiliations

University of Chicago(Current)

National Cheng Kung University

National Taiwan Normal University

Providence Portland Medical Center

City of Hope

Yi‐Hung Carol Tan is an author at University of Chicago specializing in medicine, oncology, and cancer therapeutics.

ORCID

Top concepts

Publications per year

2004–2023

24

Publications

24

CBL Is Frequently Altered in Lung Cancers: Its Relationship to Mutations in MET and EGFR Tyrosine Kinases

Yi‐Hung Carol Tan, Soundararajan Krishnaswamy, Suvobroto Nandi et al. · PLoS ONE · 2010 · 103 citations · Full text

A pan-cancer organoid platform for precision medicine

Brian M. Larsen, Madhavi Kannan, Lee Langer et al. · Cell Reports · 2021 · 94 citations · Full text

, , +17

Wild-Type p53 Overexpression and Its Correlation With MDM2 and p14ARF Alterations: An Alternative Pathway to Non–Small-Cell Lung Cancer

Yu-Chien Wang, Ruo-Kai Lin, Yi‐Hung Carol Tan et al. · Journal of Clinical Oncology · 2004 · 76 citations · Full text

Immune‐related adverse events are associated with improved response, progression‐free survival, and overall survival for patients with head and neck cancer receiving immune checkpoint inhibitors

Corey C. Foster, Marcus Couey, Sara Kochanny et al. · Cancer · 2021 · 75 citations · Full text

The EphB4 Receptor Tyrosine Kinase Promotes Lung Cancer Growth: A Potential Novel Therapeutic Target

Benjamin D. Ferguson, Ren Liu, Cleo E. Rolle et al. · PLoS ONE · 2013 · 73 citations · Full text

, , +12

1–5 of 24